How dangerous are India’s generic drugs? Very


India relies on the weak oversight of developing countries that make up the bulk of its exports – that’s how it can continue to push substandard and often deadly medicines there. — Bloomberg

FOR a nation that seeks to claim the mantle of “pharmacy to the world,” India is scandalously short on regulatory oversight.

In the last six months, its generic cough syrups have killed dozens of children, its eye drops have caused blindness and its chemotherapy drugs have been contaminated.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
India , genericdrugs , regulation , oversight , scandals

Next In Business News

Australian, New Zealand dollars rise on yen outflows, weak greenback
Amanda Lacaze to retire as Lynas CEO, MD
Japan's Nikkei hits all-time high on Wall Street rally, snap election bets
Ringgit extends gains against US$ at opening
FBM KLCI hits 1,700 as banks surge to record levels
Trading ideas: Sunway, IJM, TM, Lianson Fleet, HE, Vantris, IGB, Favelle Favco, AnwaBiru, Rexit, Melati Ehsan
S&P 500, Dow hit closing record highs; Walmart, tech climb
New major contract to boost KKB Engineering
TNB’s FY25 to FY27�net profit estimates raised�
Infrastructure rollout to bolster construction stocks

Others Also Read